Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1975 1
1982 2
1992 1
1993 1
1995 1
1999 1
2000 1
2002 1
2003 1
2004 2
2005 1
2006 2
2008 3
2009 1
2010 2
2011 2
2012 1
2013 1
2014 1
2015 3
2016 5
2018 1
2020 3
2021 5
2022 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Ovarian Dedifferentiated Carcinoma"
Page 1
Undifferentiated and dedifferentiated neoplasms of the female genital tract.
Bennett JA, Oliva E. Bennett JA, et al. Semin Diagn Pathol. 2021 Nov;38(6):137-151. doi: 10.1053/j.semdp.2020.11.002. Epub 2020 Nov 27. Semin Diagn Pathol. 2021. PMID: 33323288 Review.
In this review we discuss the clinicopathological features of undifferentiated carcinoma, dedifferentiated carcinoma, and undifferentiated uterine sarcoma, followed by a comprehensive analysis of morphological mimickers. Finally, we briefly review ovarian …
In this review we discuss the clinicopathological features of undifferentiated carcinoma, dedifferentiated carcinoma, a …
How to approach the many faces of endometrioid carcinoma.
Malpica A. Malpica A. Mod Pathol. 2016 Jan;29 Suppl 1:S29-44. doi: 10.1038/modpathol.2015.142. Mod Pathol. 2016. PMID: 26715172 Free article. Review.
This article reviews the salient features of variants of endometrioid carcinoma (ECa) that can pose a diagnostic challenge and/or are associated with unique clinicopathological findings. ...EC with clear cells should be distinguished from clear cell carcinoma by the …
This article reviews the salient features of variants of endometrioid carcinoma (ECa) that can pose a diagnostic challenge and/or are …
Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.
Kurman RJ, Shih IeM. Kurman RJ, et al. Int J Gynecol Pathol. 2008 Apr;27(2):151-60. doi: 10.1097/PGP.0b013e318161e4f5. Int J Gynecol Pathol. 2008. PMID: 18317228 Free PMC article. Review.
The accepted view of ovarian carcinogenesis is that carcinoma begins in the ovary, undergoes progressive "dedifferentiation" from a well to a poorly differentiated tumor, and then spreads to the pelvic and abdominal cavities before metastasizing to distant si …
The accepted view of ovarian carcinogenesis is that carcinoma begins in the ovary, undergoes progressive "dedifferentiation …
Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.
Bartosch C, Manuel Lopes J, Oliva E. Bartosch C, et al. Adv Anat Pathol. 2011 Nov;18(6):415-37. doi: 10.1097/PAP.0b013e318234ab18. Adv Anat Pathol. 2011. PMID: 21993268 Review.
This review focuses on the most common diagnostic pitfalls and helpful morphologic and immunohistochemical markers in the differential diagnosis between the different subtypes of endometrial carcinomas, including: (1) endometrioid versus serous glandular carcinoma, …
This review focuses on the most common diagnostic pitfalls and helpful morphologic and immunohistochemical markers in the differential diagn …
Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.
Kang EY, Tessier-Cloutier B, Duggan MA, Stewart CJR, Lee CH, Köbel M. Kang EY, et al. Histopathology. 2021 Aug;79(2):160-167. doi: 10.1111/his.14333. Epub 2021 Jun 2. Histopathology. 2021. PMID: 33432679
METHODS AND RESULTS: We evaluated 1849 tumours that included 748 endometrial carcinomas, 101 uterine carcinosarcomas/adenosarcomas, 64 uterine sarcomas, 221 cervical carcinomas and 715 ovarian carcinomas/borderline tumours by tissue microarrays (TMA). …
METHODS AND RESULTS: We evaluated 1849 tumours that included 748 endometrial carcinomas, 101 uterine carcinosarcomas/adenosarcomas, 6 …
The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
Zheng L, Zhang L, Wang XI, Katz G, Tandon N, Zhao B, Lucci J, Ding J, Zhang S. Zheng L, et al. Hum Pathol. 2022 Jun;124:45-55. doi: 10.1016/j.humpath.2022.03.009. Epub 2022 Mar 22. Hum Pathol. 2022. PMID: 35331811
However, undifferentiated endometrial carcinoma (UDEC) and dedifferentiated endometrial carcinoma (DDEC) may show some clinical and morphological overlaps with SDUS, and about 20% of reported UDEC/DDEC cases also have loss expression of SMARCA4. ...In this st …
However, undifferentiated endometrial carcinoma (UDEC) and dedifferentiated endometrial carcinoma (DDEC) may show some …
Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines.
Karnezis AN, Chen SY, Chow C, Yang W, Hendricks WPD, Ramos P, Briones N, Mes-Masson AM, Bosse T, Gilks CB, Trent JM, Weissman B, Huntsman DG, Wang Y. Karnezis AN, et al. Gynecol Oncol. 2021 Feb;160(2):568-578. doi: 10.1016/j.ygyno.2020.12.004. Epub 2020 Dec 13. Gynecol Oncol. 2021. PMID: 33328126 Free PMC article.
RESULTS: The available morphological, immunohistochemical, genetic, and clinical features indicate COV434 is derived from SCCOHT, and TOV-112D is a dedifferentiated carcinoma. Transplantation of COV434 into mice leads to increased serum calcium level. ...CONCLUSIONS …
RESULTS: The available morphological, immunohistochemical, genetic, and clinical features indicate COV434 is derived from SCCOHT, and TOV-11 …
Pteridines in the assessment of neoplasia.
Hausen A, Wachter H. Hausen A, et al. J Clin Chem Clin Biochem. 1982 Sep;20(9):593-602. doi: 10.1515/cclm.1982.20.9.593. J Clin Chem Clin Biochem. 1982. PMID: 6754854 Review.
The performance characteristics of such a method for neopterin by high performance liquid chromatography on reversed phase are given. Enhanced proliferation and dedifferentiation in cell cultures and organisms is paralleled by excretion of unconjugated pteridines into the …
The performance characteristics of such a method for neopterin by high performance liquid chromatography on reversed phase are given. Enhanc …
POLD2 and KSP37 (FGFBP2) correlate strongly with histology, stage and outcome in ovarian carcinomas.
Elgaaen BV, Haug KB, Wang J, Olstad OK, Fortunati D, Onsrud M, Staff AC, Sauer T, Gautvik KM. Elgaaen BV, et al. PLoS One. 2010 Nov 4;5(11):e13837. doi: 10.1371/journal.pone.0013837. PLoS One. 2010. PMID: 21079801 Free PMC article.
Superficial scrapings from six normal ovaries (SNO), as well as biopsies from three normal ovaries (BNO) and three benign ovarian cysts (BBOC) were analyzed for comparison. The gene expression level was related to the histological and clinical parameters of human ovaria …
Superficial scrapings from six normal ovaries (SNO), as well as biopsies from three normal ovaries (BNO) and three benign ovarian cys …
Dedifferentiated carcinoma of the ovary. A case report.
Němejcová K, Rosmusová J, Bártů M, Matěj R, Dundr P. Němejcová K, et al. Cesk Patol. 2018 Spring;54(1):33-36. Cesk Patol. 2018. PMID: 29631410 English.
We report the case of a 54-year-old female with dedifferentiated carcinoma of the ovary. Grossly, both ovaries were affected by a tumor of up to 25 mm (right ovary) and 220 mm (left ovary) in diameter. ...Other markers examined including PAX8, estrogen receptors and …
We report the case of a 54-year-old female with dedifferentiated carcinoma of the ovary. Grossly, both ovaries were affected b …
43 results